Literature DB >> 12841336

Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques.

Borja Fernández1, Andreas Kampmann, Frederic Pipp, René Zimmermann, Wolfgang Schaper.   

Abstract

The localization of osteoglycin (OG), one of the corneal keratan sulfate proteoglycans, was studied in different normal rabbit tissues, as well as in atherosclerotic lesions, by means of in situ hybridization and immunohistochemistry. OG was associated with the vasculature of all the organs analyzed. Normal aortas showed abundance of the protein in the adventitia and focally in the media. Peripheral vessels showed OG localized only in the adventitia. OG mRNA was restricted to vascular smooth muscle cells, pericytes, and fibroblasts in aorta and skeletal muscle. In striated muscle, OG was abundant and distributed in foci around muscles and vessels, whereas in visceral muscle, the protein was homogeneously distributed throughout the extracellular matrix. In all the other organs studied, OG was only associated with the vasculature, with the exception of the lung and liver. In these two organs, the protein accumulated also around cartilage, alveoli, and hepatic duct. In atherosclerotic lesions, OG mRNA was down-regulated in the media and up-regulated in the activated endothelium and thick neo-intima, whereas the protein accumulated in the front edge of migrating smooth muscle cells. We conclude that OG is a basic component of the vascular extracellular matrix. OG also plays a role in atherosclerosis, and might be useful for therapeutic interventions. In addition, the possible involvement of OG in maintaining physical properties of tissues is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841336

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  Differential splicing and alternative polyadenylation generate multiple mimecan mRNA transcripts.

Authors:  E S Tasheva; L M Corpuz; J L Funderburgh; G W Conrad
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

Review 2.  Proteoglycan-fibrillar collagen interactions.

Authors:  J E Scott
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

3.  Decorin-type I collagen interaction. Presence of separate core protein-binding domains.

Authors:  E Schönherr; H Hausser; L Beavan; H Kresse
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

4.  Expression of collagens and decorin during aortic arch artery development: implications for matrix pattern formation.

Authors:  S L Thieszen; T H Rosenquist
Journal:  Matrix Biol       Date:  1995-07       Impact factor: 11.583

5.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon.

Authors:  K G Vogel; M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

6.  Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins.

Authors:  J A Rada; P K Cornuet; J R Hassell
Journal:  Exp Eye Res       Date:  1993-06       Impact factor: 3.467

7.  Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region.

Authors:  J E Scott; C R Orford
Journal:  Biochem J       Date:  1981-07-01       Impact factor: 3.857

8.  Distribution of proteoglycans antigenically related to corneal keratan sulfate proteoglycan.

Authors:  J L Funderburgh; B Caterson; G W Conrad
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

9.  Binding of fibromodulin and decorin to separate sites on fibrillar collagens.

Authors:  E Hedbom; D Heinegård
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

10.  Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican.

Authors:  S Chakravarti; T Magnuson; J H Lass; K J Jepsen; C LaMantia; H Carroll
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

View more
  20 in total

1.  Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats.

Authors:  Xiao-Song Gu; Jun-Ping Lei; Jian-Bo Shi; Wen-ling Lian; Xiang Yang; Xing Zheng; Yong-Wen Qin
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  Shared gene expression profiles in developing heart valves and osteoblast progenitor cells.

Authors:  Santanu Chakraborty; Jonathan Cheek; Bhuvaneswari Sakthivel; Bruce J Aronow; Katherine E Yutzey
Journal:  Physiol Genomics       Date:  2008-07-08       Impact factor: 3.107

3.  Combinatorial ligand-directed lung targeting.

Authors:  Ricardo J Giordano; Julianna K Edwards; Rubin M Tuder; Wadih Arap; Renata Pasqualini
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

4.  Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration.

Authors:  Hui-Jie Zhang; Jing Wang; Hui-Fang Liu; Xiao-Na Zhang; Ming Zhan; Feng-Ling Chen
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

5.  Podocan-like protein: a novel small leucine-rich repeat matrix protein in bone.

Authors:  Yoshiyuki Mochida; Masaru Kaku; Keiko Yoshida; Michitsuna Katafuchi; Phimon Atsawasuwan; Mitsuo Yamauchi
Journal:  Biochem Biophys Res Commun       Date:  2011-06-06       Impact factor: 3.575

Review 6.  Evidence for a calcification process in the trabecular meshwork.

Authors:  Teresa Borrás; Núria Comes
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

7.  Aortic wall proteomic analysis in spontaneously hypertensive rats with a blood pressure decrease induced by 6-week load-free swimming.

Authors:  Hong Feng; Haiying Li; Derong Zhang; Yungang Zhao; Ning Jiang; Xiaoling Zhao; Y U Zhang; Junzhen Tan; Wen Fang; Yong Zhang; Wei Liu
Journal:  Biomed Rep       Date:  2015-07-10

8.  Immunoproteomic identification of bovine pericardium xenoantigens.

Authors:  Leigh G Griffiths; Leila H Choe; Kenneth F Reardon; Steven W Dow; E Christopher Orton
Journal:  Biomaterials       Date:  2008-06-02       Impact factor: 12.479

9.  Correlation between mimecan expression and coronary artery stenosis in patients with coronary heart disease.

Authors:  Youdong Hu; Junying Liu; Qingna Zhao; Peijing Xu; Ying Chen; Hualan Zhou; Xia Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis.

Authors:  Andreas Kampmann; Borja Fernández; Elisabeth Deindl; Thomas Kubin; Frederic Pipp; Inka Eitenmüller; Imo E Hoefer; Wolfgang Schaper; René Zimmermann
Journal:  Mol Cell Biochem       Date:  2008-11-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.